Form 4 Filing for CAPRICOR THERAPEUTICS, INC. - Insider Transaction

Karen Krasney, EVP, GENERAL COUNSEL of CAPRICOR THERAPEUTICS, INC. (CAPR), reported a series of transactions on June 25, 2026. Krasney acquired 24,100 shares of Common Stock at a price of $3.18 per share, increasing her post-transaction holdings to 54,647 shares. Concurrently, she disposed of 24,100 shares of Common Stock at a weighted average price of $30.38, with prices ranging from $30.00 to $30.88. This sale was conducted under a Rule 10b5-1 trading plan adopted in December 2025. Additionally, Krasney exercised a stock option to acquire 24,100 shares of Common Stock, with the shares vesting monthly starting February 1, 2022, and the underlying shares held post-transaction totaling 31,261. The reported transactions indicate a net change in direct ownership.